Advertisement
Review Article|Articles in Press

Atopic Dermatitis

Published:March 08, 2023DOI:https://doi.org/10.1016/j.pop.2022.12.004

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Primary Care: Clinics in Office Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Frazier W.
        • Bhardwaj N.
        Atopic Dermatitis: Diagnosis and Treatment.
        Am Fam Physician. 2020; 101: 590-598
        • Brunner P.M.
        • Silverberg J.I.
        • Guttman-Yassky E.
        • et al.
        Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder.
        J Invest Dermatol. 2017; 137: 18-25
        • Yaghmaie P.
        • Koudelka C.W.
        • Simpson E.L.
        Mental Health Comorbidity in Atopic Dermatitis.
        J Allergy Clin Immunol. 2013; 131: 428
        • Avena-Woods C.
        Overview of atopic dermatitis.
        Am J Manag Care. 2017; 23: S115-S123
        • Elias P.M.
        • Hatano Y.
        • Williams M.L.
        Basis for the barrier abnormality in atopic dermatitis: Outside-inside-outside pathogenic mechanisms.
        J Allergy Clin Immunol. 2008; 121: 1337
        • Bieber T.
        Atopic dermatitis.
        N Engl J Med. 2008; 358: 1483-1494
        • Morar N.
        • Cookson W.O.C.M.
        • Harper J.I.
        • et al.
        Filaggrin Mutations in Children with Severe Atopic Dermatitis.
        J Invest Dermatol. 2007; 127: 1667-1672
        • Vickery B.P.
        Skin barrier function in atopic dermatitis.
        Curr Opin Pediatr. 2007; 19: 89-93
        • Davari D.R.
        • Nieman E.L.
        • McShane D.B.
        • et al.
        Current Perspectives on the Management of Infantile Atopic Dermatitis.
        J Asthma Allergy. 2020; 13: 563
        • Lyons J.J.
        • Milner J.D.
        • Stone K.D.
        Atopic dermatitis in children: clinical features, pathophysiology, and treatment.
        Immunol Allergy Clin N Am. 2015; 35: 161-183
        • Williams H.C.
        • Jburney P.G.
        • Hay R.J.
        • et al.
        The U.K. Working Party’s Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis.
        Br J Dermatol. 1994; 131: 383-396
        • Vakharia P.P.
        • Chopra R.
        • Silverberg J.I.
        Systematic Review of Diagnostic Criteria Used in Atopic Dermatitis Randomized Controlled Trials.
        Am J Clin Dermatol. 2018; 19: 15-22
        • HanifIn J.M.
        Diagnostic features of atopic dermatitis.
        Acta Derm Venereol. 1980; 92: 44-47
        • Du Toit G.
        • Roberts G.
        • Sayre P.H.
        • et al.
        • LEAP Study Team
        Randomized trial of peanut consumption in infants at risk for peanut allergy.
        N Engl J Med. 2015; 372 (Erratum in: N Engl J Med. 2016 Jul 28;375(4):398): 803-813
        • Togias A.
        • Cooper S.F.
        • Acebal M.L.
        • et al.
        Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases–sponsored expert panel.
        World Allergy Organ J. 2017; 10: 1
        • Kristal L.
        • Klein P.A.
        Atopic dermatitis in infants and children. An update.
        Pediatr Clin North Am. 2000; 47: 877-895
        • Langan S.M.
        • Irvine A.D.
        • Weidinger S.
        Atopic dermatitis.
        Lancet. 2020; 396: 345-360
        • Asher M.I.
        • Montefort S.
        • Björkstén B.
        • et al.
        Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys.
        Lancet. 2006; 368: 733-743
        • Weidinger S.
        • Novak N.
        Atopic dermatitis.
        Lancet. 2016; 387: 1109-1122
        • Silverberg J.I.
        • Hanifin J.M.
        Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study.
        J Allergy Clin Immunol. 2013; 132: 1132-1138
        • Illi S.
        • von Mutius E.
        • Lau S.
        • et al.
        The natural course of atopic dermatitis from birth to age 7 years and the association with asthma.
        J Allergy Clin Immunol. 2004; 113: 925-931
        • Garmhausen D.
        • Hagemann T.
        • Bieber T.
        • et al.
        Characterization of different courses of atopic dermatitis in adolescent and adult patients.
        Allergy. 2013; 68: 498-506
        • Kaufman B.P.
        • Guttman-Yassky E.
        • Alexis A.F.
        Atopic dermatitis in diverse racial and ethnic groups-Variations in epidemiology, genetics, clinical presentation and treatment.
        Exp Dermatol. 2018; 27: 340-357
        • Nutten S.
        Atopic dermatitis: global epidemiology and risk factors.
        Ann Nutr Metab. 2015; 66: 8-16
        • Hadi H.A.
        • Tarmizi A.I.
        • Khalid K.A.
        • et al.
        The Epidemiology and Global Burden of Atopic Dermatitis: A Narrative Review.
        Life. 2021; 11https://doi.org/10.3390/LIFE11090936
        • Dhadwal G.
        • Albrecht L.
        • Gniadecki R.
        • et al.
        Approach to the assessment and management of adult patients with atopic dermatitis: A consensus document. Section IV: Treatment options for the management of atopic dermatitis.
        J Cutan Med Surg. 2018; 22: 21S-29S
        • Sidbury R.
        • Tom W.L.
        • Bergman J.N.
        • et al.
        Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches.
        J Am Acad Dermatol. 2014; 71: 1218-1233
        • Eichenfield L.F.
        • Tom W.L.
        • Berger T.G.
        • et al.
        Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies.
        J Am Acad Dermatol. 2014; 71: 116-132
        • Schmitt J.
        • Csötönyi F.
        • Bauer A.
        • et al.
        Determinants of treatment goals and satisfaction of patients with atopic eczema.
        J Dtsch Dermatol Ges. 2008; 6: 458-465
        • Sidbury R.
        • Davis D.M.
        • Cohen D.E.
        • et al.
        Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents.
        J Am Acad Dermatol. 2014; 71: 327-349
        • Errichetti E.
        Dermoscopy of Inflammatory Dermatoses (Inflammoscopy): An Up-to-Date Overview.
        Dermatol Pract Concept. 2019; 9: 169-180
        • EL S.
        • B A.
        • M A.
        Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
        N Engl J Med. 2017; 376: 1090-1091
        • Bieber T.
        • Simpson E.L.
        • Silverberg J.I.
        • et al.
        Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis.
        N Engl J Med. 2021; 384: 1101-1112
        • Guttman-Yassky E.
        • Thaçi D.
        • Pangan A.L.
        • et al.
        Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial.
        J Allergy Clin Immunol. 2020; 145: 877-884
        • Paller A.S.
        • Tom W.L.
        • Lebwohl M.G.
        • et al.
        Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults.
        J Am Acad Dermatol. 2016; 75 (e6): 494-503